BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.26B
Enterprise Value 39.02B
Trailing P/E 16.32
Forward P/E 135.23
PEG Ratio (5 yr expected) 12.08
Price/Sales (ttm)4.04
Price/Book (mrq)1.90
Enterprise Value/Revenue 33.93
Enterprise Value/EBITDA 626.53

Trading Information

Stock Price History

Beta (3Y Monthly) 1.39
52-Week Change 30.70%
S&P500 52-Week Change 36.42%
52 Week High 3345.15
52 Week Low 3220.05
50-Day Moving Average 3302.21
200-Day Moving Average 3286.78

Share Statistics

Avg Vol (3 month) 3171.66k
Avg Vol (10 day) 3125.54k
Shares Outstanding 524.73M
Float 21.32M
% Held by Insiders 114.62%
% Held by Institutions 178.00%
Shares Short (Jun 28, 2019) 4471.14k
Short Ratio (Jun 28, 2019) 42.9
Short % of Float (Jun 28, 2019) 42.19%
Short % of Shares Outstanding (Jun 28, 2019) 41.58%
Shares Short (prior month May 31, 2019) 4879.39k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Mar 8, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 25.05%
Operating Margin (ttm)8.87%

Management Effectiveness

Return on Assets (ttm)1.94%
Return on Equity (ttm)12.28%

Income Statement

Revenue (ttm)2.29B
Revenue Per Share (ttm)76.81
Quarterly Revenue Growth (yoy)0.40%
Gross Profit (ttm)1.23B
EBITDA 339.93M
Net Income Avi to Common (ttm)574.04M
Diluted EPS (ttm)19.00
Quarterly Earnings Growth (yoy)31.70%

Balance Sheet

Total Cash (mrq)858.99M
Total Cash Per Share (mrq)28.81
Total Debt (mrq)678.23M
Total Debt/Equity (mrq)13.94
Current Ratio (mrq)4.57
Book Value Per Share (mrq)163.11

Cash Flow Statement

Operating Cash Flow (ttm)288.09M
Levered Free Cash Flow (ttm)163.51M